DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C) is a clinical trial[1].
Key Facts
- DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C) is in the country of Australia[2].
- DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)'s instance of is recorded as clinical trial[3].
- DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)'s start time is recorded as +2013-01-31T00:00:00Z[4].
- DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)'s end time is recorded as +2015-11-30T00:00:00Z[5].
- DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)'s sponsor is recorded as Kirby Institute[6].
- DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)'s main subject is recorded as hepatitis[7].
- DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)'s main subject is recorded as hepatitis A[8].
- DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)'s main subject is recorded as hepatitis C[9].
- DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)'s number of participants is recorded as {'unit': '1', 'amount': '+14'}[10].
- DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)'s title is recorded as Direct Acting Antiviral (DAA) Based Therapy for Recently Acquired Hepatitis C[11].
- DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)'s short name is recorded as DARE-C[12].
- DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)'s minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[13].
- DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)'s ClinicalTrials.gov ID is recorded as NCT01743521[14].
- DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)'s maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+60'}[15].
- DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)'s clinical trial phase is recorded as phase IV clinical trial[16].
- DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)'s research site is recorded as Royal Adelaide Hospital[17].
- DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)'s study type is recorded as interventional study[18].